AI assistant
Repare Therapeutics Inc. — Director's Dealing 2020
Jun 19, 2020
34365_dirs_2020-06-18_a584867e-53d6-4940-acb0-8f3d56b4ebea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2020-06-18
Reporting Person: Zinda Michael (EVP, Chief Science Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 85229 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.637 | 2027-06-14 | Common Shares (10998) | Direct | |
| Employee Stock Option (right to buy) | $1.637 | 2027-06-22 | Common Shares (31618) | Direct | |
| Employee Stock Option (right to buy) | $2.062 | 2029-03-29 | Common Shares (94028) | Direct | |
| Employee Stock Option (right to buy) | $2.425 | 2029-12-16 | Common Shares (197954) | Direct |
Footnotes
F1: The original grant was for 32,992 option shares. Twenty-five percent (25%) of the shares subject to the option vested on June 14, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F2: The original grant was for 94,853 option shares. Twenty-five percent (25%) of the shares subject to the option vested on June 22, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F3: Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F4: Twenty-five percent (25%) of the shares subject to the option shall vest on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.